MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$36,405K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Sale of short-term investments
Proceeds from revolving credit f...
Maturities of short-term investm...
Others
Negative Cash Flow Breakdown
Payments for acquisition of inta...
Repayment of term loan and relat...
Accounts receivable, net
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income
17,290
8,654
268,065
27,900
Stock-based compensation expense
6,844
3,456
2,748
3,363
(gain) loss on sale and disposal of fixed assets
-
-
0
-
Depreciation and amortization
848
597
601
603
Deferred income tax
5,211
2,573
-245,852
-
Release of cost share liability
0
-
0
0
Net amortization of discount on short-term investments and debt issuance costs
35
170
243
467
Loss on extinguishment of debt
-209
-
-
-
Accounts receivable, net
6,096
-1,818
5,838
6,018
Inventories
3,259
581
-1,131
-188
Prepaid and other current and non-current assets
-5,968
3,792
3,387
1,872
Right-of-use assets
138
135
130
128
Accounts payable
-475
-2,705
3,345
-3,444
Accrued compensation
2,602
-5,905
1,849
2,168
Accrued research and development
1,190
218
708
695
Revenue reserves and refund liability
-106
364
-2,304
518
Other current and long-term liabilities
-
-
-285
-
Other accrued liabilities
474
-339
-
350
Lease liabilities
-150
-145
-141
-81
Net cash provided by operating activities
30,653
2,725
21,980
24,031
Maturities of short-term investments
11,850
15,945
13,549
20,730
Sale of short-term investments
80,933
-
-
-
Purchases of short-term investments
4,983
23,920
38,923
53,893
Capital expenditures
-
-
-12
12
Payments for acquisition of intangible assets
70,347
-
0
-
Proceeds from sale of property and equipment
-
-
0
-
Net cash provided by (used in) investing activities
17,453
-7,975
-25,362
-33,175
Proceeds from revolving credit facility
40,000
-
-
-
Net proceeds from term loan financing
-
-
0
-
Cash paid for debt issuance costs
304
-
-
-
Repayment of term loan and related fees
47,750
7,500
7,500
-
Net proceeds from issuance of common stock under equity plans
1,864
321
2,928
4,271
Repurchases of common stock in connection with employee tax withholding on rsu vesting
511
3,740
-
-
Closing purchase price payment related to asset acquisition
5,000
-
0
-
Cost share payments to a collaboration partner
-
-
0
-
Net cash (used in) provided by financing activities
-11,701
-10,919
-4,572
4,271
Net increase (decrease) in cash, cash equivalents and restricted cash
36,405
-16,169
-7,954
-4,873
Cash, cash equivalents, and restricted cash at beginning of period
24,468
40,637
48,591
56,746
Cash, cash equivalents, and restricted cash at end of period
60,873
24,468
40,637
48,591
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net income
$17,290K
(-75.67%↓ Y/Y)
Stock-based compensation
expense
$6,844K
(3.70%↑ Y/Y)
Prepaid and other
current and non-current...
-$5,968K
(-190.58%↓ Y/Y)
Deferred income tax
$5,211K
Sale of short-term
investments
$80,933K
Accrued compensation
$2,602K
(216.06%↑ Y/Y)
Accrued research and
development
$1,190K
(2379.17%↑ Y/Y)
Depreciation and
amortization
$848K
(-29.98%↓ Y/Y)
Other accrued
liabilities
$474K
(126.29%↑ Y/Y)
Loss on
extinguishment of debt
-$209K
Right-of-use assets
$138K
(114.81%↑ Y/Y)
Maturities of short-term
investments
$11,850K
(-55.87%↓ Y/Y)
Net cash provided by
operating activities
$30,653K
(3.40%↑ Y/Y)
Net cash provided by
(used in) investing...
$17,453K
(151.59%↑ Y/Y)
Canceled cashflow
$10,121K
Canceled cashflow
$75,330K
Net increase
(decrease) in cash, cash...
$36,405K
(1209.23%↑ Y/Y)
Canceled cashflow
$11,701K
Accounts receivable, net
$6,096K
(456.91%↑ Y/Y)
Inventories
$3,259K
(-53.13%↓ Y/Y)
Accounts payable
-$475K
(-112.02%↓ Y/Y)
Lease liabilities
-$150K
(-115.86%↓ Y/Y)
Revenue reserves and
refund liability
-$106K
(-103.46%↓ Y/Y)
Net amortization of
discount on short-term...
$35K
(-92.05%↓ Y/Y)
Payments for acquisition
of intangible...
$70,347K
Purchases of short-term
investments
$4,983K
(-91.79%↓ Y/Y)
Proceeds from revolving
credit facility
$40,000K
Net proceeds from
issuance of common stock...
$1,864K
(106.65%↑ Y/Y)
Net cash (used in)
provided by financing...
-$11,701K
(-1397.23%↓ Y/Y)
Canceled cashflow
$41,864K
Repayment of term loan and
related fees
$47,750K
Closing purchase price
payment related to asset...
$5,000K
Repurchases of common stock
in connection with...
$511K
Cash paid for debt
issuance costs
$304K
Buy us a coffee
RIGEL PHARMACEUTICALS INC (RIGL)
RIGEL PHARMACEUTICALS INC (RIGL)